Maxim Group upgraded shares of Achillion Pharmaceuticals (NASDAQ:ACHN) from a hold rating to a buy rating in a research report released on Monday morning, TheFlyOnTheWall.com reports. Maxim Group currently has $6.00 price objective on the stock. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares after opening at $3.63 moved to $3.68 on last trade day and at the end of the day closed at $3.68.Company price to cash ratio as 2.50.Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) showed a positive weekly performance of 4.34%.
STAAR Surgical Company (NASDAQ:STAA) was upgraded by research analysts at William Blair from a “market perform” rating to an “outperform” rating in a report released on Monday, Analyst Ratings Net reports. STAAR Surgical Company (NASDAQ:STAA) shares advanced 5.90% in last trading session and ended the day on $17.59. STAA return on equity ratio is recorded as -0.30% and its return on assets is -0.20%. STAAR Surgical Company (NASDAQ:STAA) yearly performance is 205.91%.
Shares of USANA Health Sciences, Inc.(NYSE:USNA) enjoy a nice pop in sympathy with China’s relatively gentle tap on the wrist to Nu Skin.Consensus estimates for 2014 and 2015 are earnings of $6.04 on revenues of $800M and earnings of $6.98 on revenues of $866M, respectively.233 mutual funds have positions versus 232 last year. USANA Health Sciences, Inc. (NYSE:USNA) shares moved up 9.40% in last trading session and was closed at $72.97, while trading in range of $69.69-$74.97. USANA Health Sciences, Inc. (NYSE:USNA) year to date (YTD) performance is -3.45%.
Amedica Corporation (Amedica) is a commercial biomaterial company focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. The Company market spinal fusion products and are developing products for use in total hip and knee joint replacements. Amedica Corporation (NASDAQ:AMDA) weekly performance is 11.64%. On last trading day company shares ended up $8.15. Amedica Corporation (NASDAQ:AMDA) distance from 50-day simple moving average is 12.01%. Analysts mean target price for the company is $12.50.
Leave a Reply